Obesity is associated with an increased risk for early death, heart disease and stroke, disability and several other comorbidities. Although there is concern about the potential burden on health-care services with the aging demographic and the increasing trend of obesity prevalence in older adults, evidence on which to base management strategies is conflicting for various reasons. The analytic framework for this review is based on a scoping review methodology, and was conducted to examine what is known about the diagnosis, treatment and management of obesity in older adults. A total of 492 relevant research articles were identified using PubMed, Scirus, EBSCO, Clinicaltrials.gov, Cochrane Reviews and Google Scholar. The findings of this review indicate that the current WHO (World Health Organization)-recommended body mass index, waist circumference and waist-to-hip ratio obesity thresholds for the general adult population may not be appropriate for older adults. Alternatively, weight change or physical fitness may be more useful measures of mortality and health risk in obese older adults. Furthermore, although obesity in older adults is associated with several disorders that increase functional disability, epidemiological evidence suggests that obesity is protective against mortality in seniors. Consequently, the trend toward increasing prevalence of obesity in older adults will lead to an increase in unhealthy life years and health-care costs. The findings from this review also suggest that treatment strategies for obese older adults should focus on maintaining body weight and improving physical fitness and function rather than weight loss, and that a combination of aerobic and resistance exercise appears to be the most effective strategy. In conclusion, this review demonstrates the need for more research to clarify the definition of obesity in older adults, to establish criteria for evaluating when to treat older adults for obesity, and to develop effective treatment strategies focused on functional outcomes in obese older adults.
INTRODUCTION
The increasing prevalence of obesity is a growing public health problem worldwide. In the adult population, obesity is associated with increased risk for early death, heart disease and stroke, type 2 diabetes, musculoskeletal disorders and disability. 11 Obesity in seniors (X65 years old) is growing as well; a concern given the aging demographic. For instance, between 1978/1979 and 2004, the incidence of obesity among X75-year-old Canadian adults increased from 11 to 24%, and among those aged 65 to 74 years from 20 to 25%. 2 This trend projects a significant future burden on health-care systems resulting from obesity-related disability and institutionalization.
In Canada, the burden of obesity on public health systems could be considerable as longer life expectancy and the effects of the 'baby boom' generation project a demographic trend toward an aging population. Between 2006 and 2026, the number of seniors in Canada is projected to increase from 4.3 to 8.0 million: an estimated increase of seniors in the share of the population from 13.2 to 21.2%. 3 In the elderly, obesity contributes to early onset of chronic morbidity and functional impairment. However, addressing the problem of obesity in seniors is complicated by lack of consensus regarding the potential harms of obesity, the definition of obesity and the need for treatment of obesity in the elderly. 4 --6 This scoping review was undertaken with the following aims: to produce a profile of the research on obesity and seniors that can serve as a foundation for more detailed systematic reviews; to examine possible research gaps; and to compile a database of relevant articles covering the breadth of research in this area.
METHODOLOGICAL FRAMEWORK
The analytic framework for this scoping review was performed using the methodology outlined by Arksey and O'Malley. 7 The literature search, scope and reporting of findings were guided by the primary question: 'What is known about the diagnosis, treatment and management of obesity in seniors?' The primary research question was addressed in exploring research within the associated set of subtopics:
(1) Measures of obesity (2) Mortality and obesity (3) Comorbid disease and obesity (4) Physical disability and obesity (5) Treatment strategies (6) Costs of obesity and cost effectiveness of interventions Searches focusing on the primary question and sub-topics above were conducted using the science-specific internet search engine, Scirus, and also within PubMed, EBSCO, Cochrane Reviews and Clinicaltrials.gov databases. The searches were iterative, with terms added or changed in subsequent searches to refine results. As subtopics were defined, additional searches were conducted---mainly in PubMed---to find citations specific to treatment, measures of obesity, costs and comorbidities. Using abstracts and/ or titles, articles relevant to the research question were identified and added to a Reference Manager (RefMan) database. Abstracts and, where possible, full text of the retained citations were read carefully and, if still relevant, were categorized according to the defined subtopics. Where researchers or research groups were identified as having a particular interest in geriatrics, names of these authors and/or research groups were used in a Google Scholar search to identify additional articles. English articles relevant to the research question and subtopics, those with specific focus on the elderly (465 years old) and those relevant to Canada were added to the RefMan database. There were 492 articles entered into the RefMan database and 189 articles were selected and categorized for synthesis. Of the 189 studies identified, most were included as they informed the objectives of the scoping review; however, studies were excluded if they were redundant or were duplicate studies. There was no expert discussion and consensus in selecting articles, as is done in some scoping reviews. Selected articles were those that specifically focused on seniors, and papers, editorials or conference proceedings that lent unique insight relevant to the research question and subtopics.
The remainder of this review will present the main points of research within the subtopics described above. The review will conclude outlining the knowledge gaps that exist in addressing the primary question.
RESULTS

Measures of obesity
Obesity is defined to be excess fat storage associated with elevated health risk. 6 However, measurement of what constitutes excess fat storage, and elevated health risk, in adults 465 years old is controversial. Among adults 480 years old, for example, thinness and loss of lean body mass may be a more significant problem than overweight. 8 Current World Health Organization (WHO) guidelines 8 recommend the use of body mass index (BMI), the ratio of body weight (in kg) to the square of height (in m), to define overweight and obesity. BMI classifications are: underweight: o18.5 kg m . Age-related height decline in older adults will falsely register a BMI increase, even with minimal changes in body weight. Similarly, with advancing age, fat tends to be redistributed toward more abdominal, visceral fat. Obese individuals with most of their fat stored in visceral adipose depots generally suffer greater adverse metabolic consequences than similarly overweight subjects with fat stored predominantly in subcutaneous sites. 9 With progressive obesity, ectopic intracellular lipid accumulation occurs in other nonadipose organs including the skeletal muscle, liver and pancreas that can result in insulin resistance, and eventually overt diabetes. 10, 11 Obesity is associated with increased intramyocellular lipids, 12, 13 which impairs glucose uptake at the muscle. Ectopic lipid deposition in the liver causes hepatic steatosis, which is associated with increased hepatic insulin resistance. 14, 15 Meanwhile, high levels of free fatty acids and ectopic fat accumulation inside the pancreas have also been implicated with impaired insulin secretion. Specifically, deterioration in b-cell function may be due in part to lipid accumulation in pancreatic islets. 10, 16 Increased myocardial triglyceride content in overweight humans has also been associated with increased left ventricular hypertrophy, decreased regional systolic performance and nonischemic heart failure. 17, 18 In addition, fat deposition within the renal sinus of the kidney, combined with the increased intraabdominal pressure of visceral obesity, may compress the renal vein and renal lymphatic vessels, resulting in increased renal interstitial pressure, 10, 19 favoring sodium reabsorption and arterial hypertension. Such changes in body composition will not show up in BMI measures. Yet, in routine clinical practice and epidemiological studies, BMI is well accepted as a surrogate measure of body fat. 6 Measures of absolute girth, waist circumference (WC), 20 body shape and waist-to-hip ratio (WHR) are other commonly used surrogate measures of body fat. As they measure central adiposity, they may be more useful than BMI in assessing levels of body composition in the elderly. Still, standard interpretation of anthropometric values to risk factors is complicated by genetic, environmental and sociocultural influences, as well as lifestyle, health and functional status on body composition. 21 Although radiological measurements of body fat compartments can produce accurate categorizations of obesity and the degree of fat mass in the elderly, they are not always feasible in the clinical setting, whereas surrogate measures are easily obtainable. 6 Mortality and obesity The obesity paradox. Although obesity in the general adult population is associated with higher likelihood of early death, epidemiological findings show what is referred to as 'an obesity paradox'---a beneficial or neutral, rather than detrimental, effect of obesity on length of life after the age of 65 years. 5, 6, 22 For instance, results of a study involving 22 576 hypertensive patients with coronary artery disease have shown a protective effect of obesity, even in patients with heart failure and those undergoing coronary angioplasty. 23 As diseases associated with obesity usually appear around middle age, the burden of disease is expected to have a significant impact on overweight individuals into their later years, even possibly exacerbating the effect of age-related health conditions like osteoarthritis (OA) and cognitive dysfunction. 24 Obesity increases an elderly individual's susceptibility to disability and poor outcomes, such as arthritis, stroke and diabetes, leading to poor quality of life and an increased demand for health-care services. 25 Data on the consequences of obesity in the elderly population are relatively limited and treatment of obesity in seniors is controversial, especially in frail elderly people. 6, 26 For one thing, dieting and fat loss can lead to malnutrition and/or adverse muscle (sarcopenia) or bone effects, and individuals with sarcopenic obesity are at special risk for adverse outcomes; 27 for another, obesity may provide a metabolic reserve against disease. 22 Arguments in favor of weight loss therapy are to reduce disability and to improve physical function and quality of life in overweight and obese seniors. Recent research evaluating the influence of exercise and cardiorespiratory fitness on the obesity paradox in middle-aged men with known or suspected coronary artery disease found that fitness altered the obesity paradox. 28 Compared with highly fit normal-weight men, underweight men with low fitness were found to have the highest mortality risk, and highly fit overweight men, the lowest mortality risk. Overweight and obese men with moderate fitness had mortality rates similar to those of the highly fit normal-weight reference group.
Mortality risk associated with BMI. Retrospective cohort analysis of data from the American Longitudinal Study of Aging for 7260 men and women, X70 years of age, followed from 1984 through 1990, was used to assess the relationship between BMI and mortality. A broad range and relatively high BMI (27--30 kg m --2 for men and 30--35 kg m --2 for women) was associated with minimum risk of death. 29 Obesity appeared to be protective compared with thinness or normal weight in community-dwelling older Americans. 30 Data from the University of Alabama at Birmingham Study of Aging, a longitudinal observational study of mobility among older African American and white adults, showed that unintentional weight loss and underweight BMI were associated with elevated 3-year mortality rates. No association was found with being overweight or obese on mortality, nor with intentional weight loss and mortality. 31 This study revealed that despite increasing rates of obesity: (1) a significant proportion of the older population continues to experience undernutrition; and (2) the nature of the relationship between intentional weight loss and mortality implies that there may be a beneficial effect.
The Cardiovascular Study in the Elderly 32 followed 3282 Italian subjects aged 65 --95 years for over 12 years. The results indicated that BMI inversely predicted overall and cancer mortality in men only, but not after the age of 76 years. Furthermore, The Health in Men and the Australian Longitudinal Study of Women's Health 33 followed 4677 men and 4563 women (70 --75 years) for up to 10 years and found that BMI thresholds for overweight and obese were overly restrictive for older people. Overweight older people were not shown to have greater mortality risk than those with normal weight, and being sedentary was associated with a greater risk of mortality in women than in men.
The predictive ability of BMI, and change in BMI, on mortality was estimated using data from the Canadian Study of Health and Aging on 539 Canadian seniors. The cohort was followed for deaths occurring between 1996 and 2001. 34 Weight change, especially weight loss that resulted in a BMI change of at least 2.0 units, was predictive of mortality.
Mortality risk and BMI, WC and WHR associations. The individual and combined influence of BMI and WC on mortality risk was estimated in the Cardiovascular Health Study, a longitudinal study of cardiovascular disease (CVD) and its risk factors. 35 Over 9 years, 5000 people (X65 years old) were followed. Individually, both BMI and WC were found to be negative predictors of mortality. However, higher levels of WC were associated with higher mortality risk after BMI was considered, and higher levels of BMI were associated with lower mortality risk after consideration of WC.
Data from The Rotterdam Study, a prospective, populationbased cohort study of 6296 men and women aged 55 --102 years, were used to compare BMI, WHR and WC as predictors of all-cause mortality among the elderly 36 for over 5.4 years. Sex-specific quintile cutoff points were defined for BMI 36 and WC. 37 High quintiles of WC (but not of BMI and WHR) predicted an increase of all-cause mortality among men who had never smoked. The fraction of mortality attributable to a large WC (494 cm) was almost three times higher than the fraction attributable to a high BMI (430 kg m --2 ) in men who had never smoked. Among women who had never smoked and in ex-and current smokers, high levels of body fatness did not predict increased mortality.
The association of BMI, WHR and WC with mortality and causespecific mortality was investigated in 14 833 subjects (X75 years old), who were followed for over 5.9 years. 38 An inverse relationship was found between BMI and mortality risk. WHR rather than WC predicted mortality in nonsmoking men and women, attributed to the possibility that WC alone does not account for body shape and lower trunk adiposity. The findings highlighted three points: WHO guidelines on BMI-based risk categories overestimate the risks of excess weight in people 475 years old; increased mortality risk may be more appropriately indicated by high WHR; and underweight elderly should be assessed for diet and health status.
The relationship between BMI, WC and WHR and all-cause mortality was further investigated in 4000 community-dwelling high-functioning men and women from the MacArthur Successful Aging Study, aged 70 --79 years at baseline, and followed for over 12 years for mortality. 39 In the study sample, BMI was similar in men and women (mean 26 kg m --2 ) but both WC and WHR were greater in men than in women. WHR was found to be positively associated with all-cause mortality, but neither BMI nor WC had significant associations with all-cause mortality in either gender. However, WC was found to be positively associated with the risks of coronary artery disease and CVD mortality. Dual-energy X-ray absorptiometry enables very precise in vivo measurements of fat and muscle mass, as well as the regional distribution of fat. Dual-energy X-ray absorptiometry measures of the distribution of fat and muscle mass, BMI and WHR of 4000 Chinese men and women aged X65 years were followed for over 63.3 months for mortality, and used to investigate the association between overall adiposity, the distribution of adiposity and muscle mass on survival in old age. 40 Mortality was related to body composition in men, but no corresponding relationship was found in women, except for WHR. Also, being overweight appeared favorable for survival, independent of muscle mass, in older men.
Mortality risk associated with weight change. Weight change in older adults has been found to be a more useful measure of mortality risk and future disability than static measures. 34 The relationship between BMI at age 70 years, weight change between age 70 and 75 years and 15-year mortality was investigated in a cohort study of 2628 males and females, followed from 1971 to 1981. 41 BMI ranges with lowest 15-year mortality were 27 --29 kg m --2 for males and 25 --27 kg m --2 for females. A weight loss of X10% between age 70 and 75 years showed a significantly higher risk for subsequent 5 --10-year mortality in both sexes relative to individuals with stable weights.
The relationship of variation in weight over time and of future physical limitations and mortality in the elderly was investigated in 3278 participants, aged X65 years at baseline. 42 Annual weight measurements were taken between 1992 and 1999 and summary measures of mean weight, coefficient of variation, average annual weight change and episodes of loss and gain (weight cycling) were calculated. Participants were followed from 1999 to 2006 for difficulty in activities of daily living (ADLs), incident mobility limitations and mortality. Lower weight, weight loss, higher variability and weight cycling were found to be risk factors for mortality, after adjusting for height, self-report health status and comorbidities.
Comorbid disease and obesity Most seniors are susceptible to chronic disease, and effective management of chronic conditions is part of healthy aging. Among elderly individuals, obesity increases the risks for a variety of morbid conditions, including diabetes, hypertension, 43 stroke, heart disease and metabolic syndrome, 44 to name a few. Inability to manage chronic disease can result in additional comorbidities, compromised functional capacity and reduced ability to perform ADLs.
Chronic pain is common in older adults and is highly associated with obesity. The Einstein Aging Study 45 of 840 US subjects (X70 years old) showed that obese individuals were twice as likely, and severely obese individuals (BMI 435kg m --2 ) were more than four times as likely, to have chronic pain. Prevalence of chronic pain in this elderly population was 52%; females had a strong association with prevalence of chronic pain; and pain was most commonly reported in the lower extremities and back. Possible causal links between obesity and chronic pain could be increased mechanical load, low-grade inflammation and painful consequences of obesity-related illnesses such as diabetes, peripheral artery disease and OA. 45 A cross-sectional study of 480 adults (X65 years) with chronic knee pain examined the association between muscular strength and dynamic balance, and found that higher BMI values were associated with poorer dynamic balance across all levels of knee strength. 46 Additionally, obesity accounted for a substantial proportion of disabling knee pain in an investigation of the influence of overweight and obesity on the onset and progression of knee pain and disability in community-dwelling older adults. 47 A prospective cohort study of people X50 years old who responded to a survey in 2000 (n ¼ 5784) and to a follow-up questionnaire in 2003 found that among responders with no knee pain at baseline, obesity predicted onset of severe knee pain. Considering overweight and obese categories together, B19% of new cases of severe knee pain over a 3-year period could have been avoided by a one-category shift downwards in BMI. 47 Data from a sample of 407 adults (X70 years) from the Einstein Aging Study were used to investigate potential mediators of the relationship between pain and obesity in the elderly. 48 Metabolic syndrome was present in 34% of the sample and was associated with higher pain scores. Of the individual components of the metabolic syndrome, only abdominal obesity was found to be linked to the presence of chronic pain and higher pain scores, even after adjustment for the presence of OA. This suggests a possible bi-directional influence of the pain --obesity association: pain may lead to decreased physical activity, depression and obesity, whereas metabolic derangements of obesity may predispose to pain. 48 Since the 1960s, there has been a decrease in mortality and cardiovascular risk factors in the obese population. Whether this trend has also conferred decreased risk for disability was the focus of a recent review. 49 Data analyzed from the National Health and Nutrition Examination Surveys of 1988 --1994 and 1999 --2004 on adults X60 years old (n ¼ 9928) indicated that within each period, obese individuals were more likely than normal-weight individuals to have a functional impairment, whereas data in the second period showed that obese individuals were also more likely to have ADL impairment. Examining trends over time, the prevalence of functional impairment did not change significantly among normal-weight individuals, but appeared to increase among obese individuals (from 36.8 to 42.2%). Of the health conditions considered in this study, arthritis, diabetes, congestive heart failure, myocardial infarction and stroke were significantly associated with ADL impairment. All chronic conditions were found to be significantly associated with functional impairment, except for asthma and cancer. Arthritis, stroke and congestive heart failure were the most disabling chronic conditions, each more than doubling the odds of functional impairment. Findings from this review suggest that declines in obesity-related mortality, along with a younger age at onset of obesity, could lead to an increased burden of disability within the obese older population. 49 The evidence on the association of BMI and dementia is mixed. 24 For 18 years, 392 non-demented subjects, aged 70 --88 years, were followed in the Gerontological and Geriatric Population Studies in Goteborg, Sweden. 50 Dementia risk, particularly in women, was associated with overweight (BMI X25.0 kg m --2 ) at age 70 years. This study estimated that for every 1 kg m --2 increase in BMI at age 70, the Alzheimer's disease (AD) risk increased by 36%. However, in a study on late-life BMI and dementia incidence, which followed 1255 subjects (X75 years old) for 9 years, results from the Swedish Kungholmen Project showed that after full adjustment for covariate factors, overweight subjects had lower risk of developing dementia than normal-weight subjects. 51 The results were similar when AD was separated from all dementias. Results of this study suggest a protective effect of obesity in old age. In addition, BMI loss was confirmed as a marker of incipient dementia, suggesting that the cognitive profile of elderly people with unexplained weight loss should be considered. 51 Similarly, higher BMI at baseline was also significantly associated with a lower risk of AD in 1836 Japanese Americans (mean age 71.8 years) in the Kame Project, 52 who were dementia free at baseline (1992 --1994) and followed for incident dementia through 2001. A slower rate of decline in BMI in late life was found to be associated with a lower risk of dementia, with the association stronger for those who were overweight or obese, compared to normal or underweight at baseline. This suggests that 'a low BMI or faster decline in late life may be preclinical indicators of an underlying dementing illness, especially for those who were initially overweight or obese'. 52 Findings from a systematic review of 10 prospective cohort studies of older adults (40 --80 years at baseline) recorded mixed results, with only a few indicating significant risk relationship of adiposity to AD. 53 However, a meta-analysis conducted on 7 of the 10 studies suggests an independent effect of obesity on dementia in general and incident AD in particular. 53 Both obesity and underweight were found to increase the risk of dementia (U-shaped relationship of BMI to dementia risk); overweight was not found to be a significant risk factor. Weight gain and high WC or skin-fold thickness showed increased risks of dementia in all included studies.
Physical disability and obesity Functional decline associated with BMI, WC and WHR. Obesity and older age are associated with several conditions that are risk factors for subsequent disability: OA, hypertension, type 2 diabetes and CVD. The impact of increased fat mass on disability and functional limitations in the elderly is thus significant from a clinical and a public health standpoint. However, there is considerable lack of understanding of the functional and healthrelated implications of anthropometric indicators in older people. 8 The association of BMI and subsequent disability and mortality was investigated using data from five sites of the Established Populations for Epidemiologic Studies of the Elderly. In this study, 8359 non-Hispanic white Americans, 1931 African Americans and 2435 Mexican Americans, X65 years old, who were not disabled at baseline, were followed for 7 years. 54 Disability-free life expectancy was found to be greatest among subjects with a BMI of 25 --30 kg m --2 . Subjects with BMI o18.5 kg m --2 or 430 kg m --2 at baseline were significantly more likely to experience disability during the follow-up period.
Mobility is important for minimizing the risks of disability, CVD and mortality. A systematic review of 13 cross-sectional and 15 longitudinal studies found that increased adiposity combined with relative or absolute reduction in skeletal muscle influences the development of mobility and functional impairments. 55 The threshold at which mobility limitations appear to develop is BMI between 30 and 35 kg m --2 . The evidence suggested that fat mass may be more predictive than fat-free mass on lower body mobility, and that obese women (irrespective of measurement) might be more susceptible to development of mobility disability. The authors advocated a need for longitudinal studies examining overall body composition fat and muscle mass or change on future disability. 55 The usefulness of BMI as a surrogate measure and any advantage of actual body composition measurements over BMI in assessing risk factors for physical functioning in older adults was investigated within a cross-sectional study of 4000 men and women X65 years old. 56 Stratified by age and sex, data on body composition, grip strength and timed 6 m walk were collected and analyzed in relation to groupings of subjects within five categories of BMI, using Asian criteria for health-related risks. Between-group differences in physical performance measures and body composition were also analyzed, adjusting for age, physical activity level and presence of chronic disease. Subjects in the two obese categories had a significantly greater number of impaired ADLs compared with the underweight and normal-weight groups; those with BMI X30 kg m --2 had the worst walking performance; and groups with BMI in the normal and overweight range had optimal performance. Muscle function was found to be adversely affected by increasing fat mass, even after adjustment for BMI. 56 Functional decline associated with weight change. Data from the Australian Longitudinal Study of Ageing of 1272 community-living older adults (685 males and 586 females), X70 years old, were used to evaluate the predictive value of BMI, WC, WHR and percentage weight change on function and mobility. 57 Anthropometric assessments taken in 1992 were evaluated for their ability to predict functional and mobility limitation assessed at 2-year follow up. Analysis of the data showed that BMI 430 kg m --2 or WC 4102 cm in males and 488 cm in females increased the risk of functional and mobility limitations. Over 2 years, a loss of 10% body weight significantly increased the risk of functional and mobility limitations. It appears that maintaining weight within older adults, irrespective of initial body weight, may be important in preventing functional and mobility limitations.
As previously mentioned, the relationship between weight variation in the elderly and future physical limitations, along with mortality, was investigated in a larger sample of adults X65 years old at baseline. 42 Annual weight measurements were taken between 1992 and 1999 and summary measures of mean weight, coefficient of variation, average annual weight change and episodes of loss and gain (weight cycling) were calculated. Participants were followed from 1999 to 2006 for ADL difficulty, incident mobility limitations and mortality. Higher mean weight, weight variability and weight 'cycling' were found to increase the risk of new onset of ADL difficulties and mobility limitations.
The association between weight loss and weight gain after middle age and the prevalence of late disability was studied in the Progetto Veneto Anziani Study, 58 an observational cohort study of 1187 male and 1723 female Italian subjects aged X65 years. At baseline, anthropometric measurements were collected for each participant, and participants were asked to recall their weight at age 50. Baseline BMI, and BMI at age 50, were calculated and classified per WHO guidelines. Percentage weight change from age 50 to 65 years was calculated and information on ADL was collected during a home interview. Data were analyzed to associate disability status (impairment in X1 ADL) as it related to current BMI, BMI at age 50 and weight change (weight gain 410%, weight gain 5 --10%, weight stable, weight loss 5 --10%, weight loss 410%) in the intervening period. Weight gain after middle age was found to be associated with late disability, particularly in participants who were already obese. Weight loss after middle age was associated with disability only in normalweight participants, but this association was attenuated after adjustment for chronic diseases. 58 Treatment strategies Weight loss and maintenance of a healthy body weight are general recommendations for improving quality of life and decreasing obesity-related health risks. However, in the elderly, comorbidities, frailty, sarcopenia, mobility and functional limitations and influence of social and living environments make practical recommendations for weight management difficult. 59 Generally, weight loss prescription should ensure that treatment incorporates measures to avoid loss of bone and muscle mass in the elderly. 22, 60 This section summarizes some of the research that has examined both the positive and negative outcomes of weight loss in older adults.
Nonpharmacological interventions: exercise and diet. A recent systematic review by Bales and Buhr 61 summarized the findings of 16 articles based on 5 trials that examined intentional weight loss in older people. Please refer to Table 1 for summaries of these trials, as well as for summaries of additional trials also considered for inclusion as part of the present review. Furthermore, Table 2 summarizes studies that demonstrate the more specific effects of nonpharmacological weight loss interventions on inflammation, bone density and metabolic parameters in older adults. Overall, the findings from these trials suggest that exercise and dietary weight loss are useful not only for reducing weight in the elderly, but also for managing chronic conditions associated with obesity in the geriatric population, such as OA and CVD. Although improvements in physical function were frequently observed, the loss of bone mass associated with exercise and dietary weight loss programs puts older adults at greater risk for fractures. More research is needed to assess the effects of different modes and intensities of exercise on weight loss in the elderly, with consideration of the effect on bone metabolism, inflammation and metabolic factors. 65, 77, 79 Pharmacological interventions. Despite the availability of approved obesity drugs, physicians are reluctant to prescribe weight loss drugs to the elderly. 80 This is probably because weight loss drugs have not been extensively studied in older people, raising concerns about the potential drug side effects and interactions 81 and uncertainty about the utility of weight loss in the elderly. Three major drug options for the long-term treatment of obesity are Orlistat (Xenical/Alli), Sibutramine (Reductil/Meridia) and Rimonabant (Acomplia/Zimulti). 82 Orlistat is a gastric and pancreatic lipase inhibitor that reduces dietary fat absorption by B30%, 83 but has been associated with adverse gastrointestinal side effects. 83, 84 Sibutramine is a centrally acting monaminereuptake inhibitor 83 that acts to increase satiety, and has been associated with insomnia, nausea, dry mouth and constipation, 83 as well as elevated blood pressure and tachycardia. 83, 84 Rimonabant is an endocannabinoid receptor antagonist that produces a dose-dependent reduction in food intake, 83 and has been associated with psychiatric disorders. 83, 84 All antiobesity drug trials have been limited by their high attrition rates 83 --85 and lack of long-term morbidity and mortality data. 83 As new drugs are developed, the assessment process needs to include both surrogate end points (that is, weight loss) and clinical outcomes to build confidence in physicians and patients in addressing the benefits, risks and costs. 83 Weight loss surgery. Bariatric surgery appears to be the only treatment for obesity in randomized controlled trials to show long-term weight loss. 86 Common procedures used for weight loss include gastric banding, Roux-en-Y gastric bypass and sleeve gastrectomy. Bariatric surgery has been shown to lead to sustained weight loss, resolution of comorbidities and improved life expectancy of those with morbid obesity. 86 A retrospective analysis of the experience of 197 patient X65 years old, who underwent weight loss surgery from January 2000 to December 2007, showed that surgery was effective in producing significant excess weight loss, reduction in daily medication use and improvement in quality of life. 87 Weight loss surgery was associated with a 'low mortality rate' and an 'acceptable morbidity profile'. 87 A systematic review of weight loss surgery concluded that surgery appears to be a 'clinically effective and cost-effective intervention for moderately to severely obese people compared with non-surgical interventions'. 88 However, uncertainties remain regarding detailed data on patient quality of life; impact of surgeon experience on outcome; late complications leading to reoperation; duration of comorbidity remission; and resource use. 88 A study of the outcome of bariatric surgery in the elderly performed at 99 academic centers in the United States between 1999 and 2005 found that bariatric surgery in the elderly (460 years old) represented 2.7% (n ¼ 1339) of all bariatric operations performed at academic centers, and that although morbidity and mortality was higher in the elderly, bariatric surgery was considered 'as safe as other gastrointestinal procedures because the observed mortality is better than the expected (risk-adjusted) mortality'. 89 Costs of obesity and cost effectiveness of interventions As health-care providers are faced with an increasingly older population and associated increases in demand for health services, cost effectiveness of treatment is a crucial concern.
Reimbursement for treatment of obesity as a distinct disease remains a major challenge. 90 The current and future costs due to obesity, obesity-related treatment and inaction should be the subject of more detailed analyses. 90 Several approaches have demonstrated the financial burden of obesity on public institutions and individuals. Regression analysis on a nationally representative data set estimated that of the total medical expenditures in the United States in 1998, 9.1% was attributable to overweight/obesity, half of which was financed by public funds. 91 In Canada, the proportions of total health-care expenditure in 2001 associated with obesity and physical inactivity were 2.2% and 2.6%, respectively. ).
4 Groups:
(1) Combined weight loss+reduced sodium, (2) Reduced sodium alone, (3) Weight loss alone, (4) Control.
The primary analyses revealed a reduction in the combined end point of high blood pressure, antihypertension medication or cardiovascular event for all three treatment groups, with the combined weight loss and reduced sodium group showing the best result. ), mild to moderate frailty. Both fat and lean mass decreased significantly and absolute decreases were similar among groups. Calorie restriction group showed larger relative lean mass lost as a proportion of total weight lost. Changes in visceral fat were inversely related to increases in aerobic fitness, but addition of exercise also resulted in lean mass loss. Intensity of exercise did not show an effect on location of fat loss.
Exercise-Induced Changes in Metabolic Factors in Elderly Adults 44, 73 18 adults randomized. Overweight or obese (BMI range 26 --37 kg m --2 ), nonsmoking, sedentary adults (71±1 years), who were weight stable over the previous 6 months. To standardize dietary intake, each subject was provided a mixed diet during 4 days of controlled feeding before baseline week and after intervention week.
3 Groups (12-week duration): (1) Moderate-intensity training (50% of VO 2 max), (2) High-intensity training (75% of VO 2 max), (3) Control group.
No change was recorded in BMI or percentage of fat in any of the groups. A significant increase was observed in VO 2 max in the medium-and high-intensity groups, but not in the control group.
Resistance exercise effect on leptin and adiponectin study 74, 75 40 men randomized. Inactive men (65 --82 years).
4 Groups: (1) Control, (2) Low-intensity resistance exercise, (3) Moderate-intensity resistance exercise, (4) High-intensity resistance exercise. Resistance training (6 months, 3 days per week, 10 exercises in 3 sets) was followed by 6 months of detraining.
All exercise groups demonstrated a decrease in BMI during training. Skinfold sum decreased in moderate and high intensity groups. WHR decreased only in the high-intensity group after training, but returned to baseline after detraining. The combination of resistance and aerobic exercise was the optimal exercise strategy for simultaneous reduction in insulin resistance and functional limitation in previously sedentary, abdominally obese older adults.
Abbreviations: BMI, body mass index; OA, osteoarthritis; VO 2 max, maximal oxygen uptake; WHR, waist-to-hip ratio.
Review: obesity in older adults JE DeCaria et al Andreyeva et al. 93 showed that for a representative American sample population aged 54 --69 years, a heavier weight class as defined by BMI is associated with increasingly higher health-care costs, particularly in outpatient care. Similarly, Yang and Hall 94 created a simultaneous equation system to modeling dynamic health factors, which ascribed higher lifetime health costs from age 65 years to overweight and obese men (6 --13% more than for normal-weight men) and women (11 --17% more than for normalweight women).
In the literature, disagreement persists over the extent to which obesity influences mortality, and therefore the subsequent financial burden given the greater number of years lived. Lakdawalla et al. 95 found similar life expectancies for obese versus normal-weight 70 year olds, but B34% higher Medicare expenses for obese individuals. Conversely, van Baal et al. 96 concluded that health interventions were ineffective in decreasing health expenditure precisely because of 'diseases unrelated to obesity in life-years gained'.
Lifestyle interventions targeting knee pain in obese and overweight seniors is estimated to be cost effective, although with a large degree of uncertainty, 97 using classic cost --utility analysis (quality-adjusted life year (QALY)/$). Use of subjective performance measures are suggested to be 'stronger drivers of downstream health service utilization' for interventions targeting knee OA in overweight and obese seniors. 98 Findings from a meta-analysis indicate cost effectiveness for healthcare-based interventions aimed at improving physical activity in older people. 99 This study noted that cost efficiency can rely on setting and specific populations, and that there remains a lack of evidence regarding specific methods and populations. Intervention programs encouraging the use of pedometers and mass media-based community campaigns Reduced chronic inflammation in older obese men and women, as measured by serum concentrations of inflammatory biomarkers (C-reactive protein, interleukin-6 and soluble tumor necrosis factor-a). Exercise training was not found to have had an effect on these inflammatory markers.
Bone density
Trial of Nonpharmacological Interventions (TONE) 65 Data on a subset of 67 overweight, postmenopausal women from TONE trial. ), mild to moderate frailty. 68 2 Groups (26 weeks): (1) Group exercise training (3 days/week, 90 min each)+diet therapy, (2) Control.
Data on 27 frail, obese adults. Even when combined with exercise, there was a decrease in hip BMD, which directly correlated with a decrease in body weight.
Metabolic parameters
The Arthritis, Diet and Activity Promotion Trial (ADAPT) 78 Sedentary overweight and obese older adults (mean BMI 34.5 ± 5.4 kg m -
) with radiographic OA and daily pain. Significant main effect of weight loss on serum leptin in the diet and diet+exercise groups compared with the other two groups. Serum leptin was also found to be related to selfreported physical function. In all participants, lower levels of baseline serum leptin predicted larger weight loss. 44, 73 Overweight or obese (BMI range 26 --37 kg m --2 ), nonsmoking, sedentary adults (71±1 years), who were weight stable over the previous 6 months. To standardize dietary intake, each subject was provided a mixed diet during 4 days of controlled feeding before baseline week and after intervention week.
Exercise-Induced Changes in Metabolic Factors in Elderly Adults
No weight loss was recorded in any of the groups, and only the high-intensity training group showed a marked decrease in insulin resistance. Abdominal visceral fat decreased in the high-intensity group, but no such change was noted in the medium-intensity or the control groups. Exercise training programs in the elderly that do not result in weight or fat loss may only improve insulin action through short-term improvements in glycogen metabolism. Moderate-or high-intensity exercise training in the absence of weight loss appears not to normalize metabolic dysfunction in a short-term intervention. Lasting improvement may need additional dietary modifications that encourage weight loss.
Resistance exercise effect on leptin and adiponectin study 74, 75 Inactive men (65 --82 years)
Resistance training and detraining were found to alter leptin and adiponectin in an intensity-dependent manner. Leptin and adiponectin changes were strongly associated with resting metabolic rate and anthropometric changes. Leptin was diminished by all treatments; however, adiponectin increased only in the high-intensity group. Leptin and adiponectin were found to be strongly associated with resting metabolic rate anthropometric changes. Resistance exercise was advocated as an effective approach for weight management and metabolic control in overweight elderly individuals.
Abbreviations: BMD, bone mineral density; BMI, body mass index; OA, osteoarthritis; VO 2 max, maximal oxygen uptake.
were found to be dominant cost-effective strategies; general practitioner referral to an exercise physiologist was the least cost-effective option considered in the study. 100 
DISCUSSION
This scoping review has summarized the research on obesity in older adults and has identified several knowledge gaps in the areas of diagnosis, pathology and treatment. Although there is concern about the potential burden on health-care services with the aging demographic and the increasing trend of obesity prevalence in seniors, evidence on which to base management strategies is conflicting for various reasons. Research targeting the knowledge gaps identified in this review will have significant impact on future practice regarding the diagnosis and management of obesity in older adults. There is as yet no consensus on the definition of obesity in the elderly. The classifications defined by the WHO for BMI and the 'at-risk' values for WC and WHR are not appropriate targets for seniors. Furthermore, anthropometric data alone are relatively poor indicators of health risk in older people. 101 For instance, although BMI is widely used, it does not capture the effect of agerelated changes in body composition. Being overweight in midlife is known to be hazardous to survival; however, most epidemiological findings show a beneficial or neutral, rather than detrimental, effect of a high BMI on the length of life after the age of 65 years. More research is needed regarding the long-term effects of obesity, overweight and weight stability progressing from adulthood into old age on health, disease and function, 102 to establish criteria for healthy weight in seniors and to inform treatment and prevention strategies.
Although evidence shows a protective effect of obesity on mortality in seniors, it is associated with several disorders that increase functional disability and decrease the ability to perform ADLs. This can lead to increased demand for health services, institutionalization and decrease in quality of life. However, there is insufficient evidence of clinical relationships with obesity in seniors to advocate treatment to therapeutic goals, as there is in younger age groups. Future research should study the causal links that lead to obesity-related morbidity so that appropriate interventions can be implemented to improve function and quality of life of older obese individuals.
Weight loss in the elderly can result in confounding outcomes depending on the way the weight is lost. For instance, although it has been observed that a state of overweight or obesity may be protective from mortality risk in old age, weight loss in the elderly can indicate either a reduced risk of morbidity or a state of deteriorating health. Intentional weight loss programs can promote fat-free mass and decrease fat mass, whereas unintentional weight loss can lead to decreased fat-free mass and an underestimation of fat mass present in patients. Furthermore, evidence on intentional weight loss suggests benefits in controlling cardiovascular risk factors, 103 --105 reducing medications for weight-related health conditions 66 and OA. 63, 106 Conversely, unintentional weight loss is commonly associated with increasing severity of many chronic conditions in the elderly, and usually involves loss of lean tissue. 101 Furthermore, the increased morbidity-and mortality-related consequences of unintentional weight loss may amplify the observation that a state of overweight or obesity may be protective in older adults. Therefore, weight loss outcomes observed in young or middle-aged adults cannot be applied generally to older adults, and assessment of body composition is particularly important in determining the impact of weight loss on the health of an older individual.
In older adults, energy expenditure, and therefore energy requirement, is primarily reduced because of significant decreases in basal metabolic rate, as a result of B15% loss of lean body mass between the third and eighth decade of an adult life, 107 and significant decreases in physical activity. 108, 109 Age-related decreases in energy requirements lead to decreased energy intake, which is associated with decreases in nutrient intake that are typically ingested in proportion to dietary energy, 110, 111 including protein. Because of increasingly reduced energy requirements and intake in the elderly, creating an energy balance deficit to illicit weight loss without further restricting nutritional intake is challenging. Thus, for many older adults losing weight to appreciate proposed health benefits in physical function and quality of life may be neither achievable nor sustainable.
As with any chronic condition, effective management of obesity must be lifelong with efficacy assessed in terms of minimizing risk factors, disease improvement or reducing clinical end points. 80 In the elderly, exercise (a combination of aerobic and resistance) appears to be the most effective treatment strategy in helping to decrease or maintain body weight and improve function and fitness. However, there is insufficient evidence to base recommendations for weight loss in elderly people. Practical recommendations for weight management in the elderly are challenging because of the obesity paradox and the lack of substantial research in this population. Hence, decisions as to whether or not to advise weight loss must be individualized to the patient, taking into consideration the patient's underlying medical problems, functional status and living environments. Clinicians should also consider the inclusion of meal replacements and/or supplements as a precaution for nutrient deficiency in older adults undergoing weight loss, as well as goals related to physical fitness and functional improvement, as obese individuals who are fit show lower risk of mortality than lean individuals who are unfit.
The prevalence of obesity is associated with higher costs of health-care utilization. Limited evidence shows cost effectiveness for health-care-based interventions aimed at improving physical activity in seniors. However, there is a lack of evidence regarding specific methods and populations. More research is needed to understand how obesity affects function to inform appropriate and cost-effective prevention and treatment strategies.
In conclusion, further research is necessary to improve understanding of the potential harms of obesity, the definition of obesity, the need for treatment and evidence for effective treatment strategies addressing obesity in the elderly. Additionally, more study is needed to understand the levels and changes in body composition leading up to and during old age to better classify and advocate specific treatment of obesity in seniors.
